Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | MMP2 | P08253 | 4/20 | 0.98 |
| ▸ | MMP9 | P14780 | 4/20 | 0.98 |
| ▸ | PRKD3 | O94806 | 3/20 | 0.98 |
| ▸ | PRKCG | P05129 | 3/20 | 0.98 |
| ▸ | PRKCB | P05771 | 3/20 | 0.98 |
| ▸ | PRKCA | P17252 | 3/20 | 0.98 |
| ▸ | PRKCH | P24723 | 3/20 | 0.98 |
| ▸ | PRKCI | P41743 | 3/20 | 0.98 |
| ▸ | PRKCE | Q02156 | 3/20 | 0.98 |
| ▸ | PRKCQ | Q04759 | 3/20 | 0.98 |
| ▸ | PRKCZ | Q05513 | 3/20 | 0.98 |
| ▸ | PRKCD | Q05655 | 3/20 | 0.98 |
| ▸ | PRKD1 | Q15139 | 3/20 | 0.98 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.94 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.67 |
| ▸ | BACE1 | P56817 | 4/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Procyanidin B2 SCHEMBL677697 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL15142352 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL718738 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL18685718 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL14626386 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL23251016 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL14413656 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL20661403 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL22043665 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 | |
| Procyanidin B2 SCHEMBL13285131 | 1.00 | SNCA (1.00) | SNCAHSD17B10ALOX15CYP1A2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230095383-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | DST PHARMA, INC. | 2023-03-30 | — | — | US | disclosed |
| WO-2021188096-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | DST PHARMA, INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| US-20200347153-A1 | METHODS FOR FORMING INCLUSION COMPLEXES WITH HYDROPHILIC BETA-CYCLODEXTRIN DERIVATIVES AND COMPOSITIONS THEREOF | TAKA USA, INC. (US) | 2020-11-05 | — | — | US | disclosed |
| US-20070282422-A1 | Medical devices and methods for local delivery of elastin-stabilizing compounds | COOK INCORPORATED | 2007-12-06 | — | — | US | disclosed |
| US-20070282422-A1 | Medical devices and methods for local delivery of elastin-stabilizing compounds | COOK INCORPORATED | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230095383-A1 | METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS | FABP2, FABP6, CALU | SNCA 4130/4885HSD17B10 4225/4885ALOX15 239/4885 |
| US-20200347153-A1 | METHODS FOR FORMING INCLUSION COMPLEXES WITH HYDROPHILIC BETA-CYCLODEXTRIN DERIVATIVES AND COMPOSITIONS THEREOF | DSC1, PDCD2L, GANC | SNCA 1135/4885HSD17B10 137/4885ALOX15 2286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.